Expression of multidrug resistance-1 protein correlates with disease activity rather than the refractoriness to methotrexate therapy in rheumatoid arthritis

Clinical Rheumatology

Volumn 28, Issue 4, 2009, Pages 427-433

  Agarwal, V ^a   Mittal, S K ^a   Misra, R ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Drug resistance; MDR 1; Methotrexate; P glycoprotein; Refractory

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUCOCORTICOID; GLYCOPROTEIN P; HYDROXYCHLOROQUINE; METHOTREXATE; MULTIDRUG RESISTANCE PROTEIN 1; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG DOSE INCREASE; DRUG EFFICACY; FEMALE; FLOW CYTOMETRY; HUMAN; MALE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SCORING SYSTEM;

ADULT; ARTHRITIS, RHEUMATOID; DRUG RESISTANCE; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTES; MALE; METHOTREXATE; MIDDLE AGED; P-GLYCOPROTEIN; TREATMENT OUTCOME;

EID: 61549114044     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-008-1071-1     Document Type: Article

References (27)

1. American College of Rheumatology (2008) 2008 recommendations for the use of nonbiologic and biologic disease modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 59:762-784
2. Lindqvist E, Saxne T, Geborek P, Eberhardt K (2002) Ten year outcome in a cohort of patients with early rheumatoid arthritis: Health status, disease process, and damage. Ann Rheum Dis 61:1055-1059
3. Situnayake RD, McConkey B (1990) Clinical and laboratory effects of prolonged therapy with sulfasalazine, gold or penicillamine: The effects of disease duration on treatment response. J Rheumatol 17:1268-1273
4. Morgan C, Lunt M, Brightwell H, Bradburn P, Fallow W, Lay M, Silman A, Bruce IN (2003) Contribution of patient related differences to multidrug resistance in rheumatoid arthritis. Ann Rheum Dis 62:15-19
5. Dean M, Allikmets R (2001) Complete characterization of the human ABC gene family. J Bioenerg Biomembr 33:475-479
6. Jorgensen C, Sun R, Rossi JF, Costes J, Richard D, Bologna C et al (1995) Expression of a multidrug resistance gene in human rheumatoid synovium. Rheumatol Int 15:83-86
7. Maillefert JF, Duchamp O, Genne P, Solary E, Tavernier C (2000) Effects of cyclosporine at various concentrations on dexamethasone uptake in multidrug resistant cells. Ann Rheum Dis 59:146-148
8. Bourgeois S, Gruol DJ, Newby RF, Rajah FM (1993) Expression of an MDR gene is associated with a new form of resistance to dexamethasone-induced apoptosis. Mol Endocrinol 7:840-851
9. Maillefert JF, Duchamp O, Piroth C, Solary E, Tavernier C, Genne P (1997) Dexamethasone efflux associated with P-glycoprotein in human multidrug resistant cell lines. In: Galteau MM, Delwaide P, Siest G, Henny J (eds) Biologie prospective: Comptes Rendus du 9e Colloque de Pont à Mousson. John Libbey Eurotext, Paris, pp 489-492
10. Maillefert JF, Maynadié M, Tebib JG, Aho S, Walker P, Chatard C et al (1996) Expression of the multidrug resistance glycoprotein 170 in the peripheral blood lymphocytes of rheumatoid arthritis patients. The percentage of lymphocytes expressing glycoprotein 170 is increased in patients treated with prednisolone. Br J Rheumatol 35:430-435
11. Matsubara T, Funahashi K, Ohuchi N (1998) Detection of responders and non-responders of gold compounds by analysis of multidrug resistance (MDR)-1 gene in RA patients (abstract). Arthritis Rheum 41:S158
12. Yudoh K, Matsuno H, Nakazawa F, Yonezawa T, Kimura T (1999) Increased expression of multidrug resistance of P-glycoprotein on Th1 cells correlates with drug resistance in rheumatoid arthritis. Arthritis Rheum 42:2014-2015
13. van der Heijden J, de Jong MC, Dijkmans BA, Lems WF, Oerlemans R, Kathmann I, Schalkwijk CG, Scheffer GL, Scheper RJ, Jansen G (2004) Development of sulfasalazine resistance in human T cells induces expression of the multidrug resistance transporter ABCG2 (BCRP) and augmented production of TNF alpha. Ann Rheum Dis 63:138-143
14. Rangnathan P, McLeod HL (2005) Methotrexate and long term treatment of rheumatic disease: Comment on article by Kremer. Arthritis Rheum 52:670-671
15. Hider SL, Owen A, Hartkoorn R, Khoo S, Back D, Silman AJ, Bruce IN (2006) Down regulation of multidrug resistance protein-1 expression in patients with early rheumatoid arthritis exposed to methotrexate as a first disease-modifying antirheumatic drug. Ann Rheum Dis 65:1390-1393
16. van Gestel AM, Prevoo MLL, van't Hof MA, van Rijswijk MH, van de Putte LBA, van Riel PLCM (1996) Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis: comparison with the preliminary American College of Rheumatology and the World health Organisation/International League Against Rheumatism Criteria. Arthritis Rheum 39:34-40
17. Young IT (1977) Proof without prejudice: Use of the Kolmogorov-Smirnov test for the analysis of histograms from flow systems and other sources. J Histochem Cytochem 25:935-941
18. Tsujimura S, Saito K, Nawata M, Nakayamada S, Tanaka Y (2008) Overcoming drug resistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis. Ann Rheum Dis 67:380-388
19. Tsujimura S, Saito K, Nakayamada S, Nakano K, Tsukada J, Kohno K et al (2004) Transcriptional regulation of multidrug resistance-1 gene by interleukin-2 in lymphocytes. Genes Cells 9:1265-1273
20. Salmon SE, Dalton WS (1996) Relevance of multidrug resistance to rheumatoid arthritis: Development of a new therapeutic hypothesis. J Rheumatol 44:97-101
21. Norris MD, de Graff D, Haber M, Kavallaris M, Madafiglio J, Gilbert J et al (1996) Involvement of MDR1 p-glycoprotein in multifactorial resistance to methotrexate. Int J Cancer 65:613-619
22. De Graff D, Sharma R, Mechetner EB, Schimke RT, Roninson IB (1996) P-glycoprotein confers methotrexate resistance in 3T6 cells with deficient carrier-mediated methotrexate uptake. Proc Natl Acad Sci U S A 93:1238-1242
23. Hider SL, Hoggard P, Khoo S, Back D, Bruce IN (2005) Drug efflux transporters in rheumatoid arthritis: Comment on the article by Kremer. Arthritis Rheum 52:670-672
24. Hooijberg JH, Broxterman HJ, Kool M et al (1999) Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2. Cancer Res 59:2532-2535
25. Zeng H, Chen ZS, Belinsky MG, Rea PA, Kruh GD (2001) Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: Effect of polyglutamylation on MTX transport. Cancer Res 61:7225-7232
26. Volk EL, Farley KM, Wu Y, Li F, Robey RW, Schneider E (2002) Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance. Cancer Res 62:5035-5040
27. Wolf J, Stranzl T, Filipits M, Pohl G, Pirker R, Leeb B, Smolen JS (2005) Expression of resistance markers to methotrexate predicts clinical improvement in patients with rheumatoid arthritis. Ann Rheum Dis 64:564-568